A government shutdown of the FDA, CDC and NIH will likely have widespread and long-lasting consequences for public health.
By Erin Mershon, STAT and Ike Swetlitz, STAT
A wearable device claiming to block the pain of opioid withdrawal has been cleared by the Food and Drug Administration under a new expedited review process.
By Max Blau, STAT
Patients can track their dosage on their smartphone and allow their doctors or caregivers to access the information through a website.
By Associated Press
As the first gene therapies approach the market, drug makers, insurers, and patients are debating complex questions about cost, value, and payment plans.
By Meghana Keshavan, STAT
By Laura Santhanam
The Senate Health, Education, Labor and Pensions Committee is scheduled to convene at 10 a.m. ET to discuss how well the federal government has responded to a mounting public health crisis over opioids.
By Ed Silverman, STAT
The Food and Drug Administration has asked Endo Pharmaceuticals to withdraw its Opana ER painkiller over concerns that the drug is too easily abused, the first time the agency has made such a move.
By Kate Sheridan, STAT
The FDA issued its strongest level of drug warnings Thursday concerning opioid pain-reliever use in children.
By Sheila Kaplan, STAT
Congressional supporters of the tobacco industry have proposed legislation to help e-cigarette companies escape rules adopted under Obama.
By PBS NewsHour
The U.S. Drug Enforcement Administration (DEA) has received thousands of comments on whether it should make kratom, a popular painkiller, illegal.
Support Provided By: Learn more